Evidence map›Paper›PMID 36826572›Full record

ArticleJournal of cardiovascular development and disease2023

Does an eHealth Intervention Reduce Complications and Healthcare Resources? A mHeart Single-Center Randomized-Controlled Trial.

Mar Gomis-Pastor, Sonia Mirabet Perez, Anna De Dios Lopez, Vicenç Brossa Loidi, Laura Lopez Lopez, Rebeca Pelegrin Cruz, Mª Antonia Mangues Bafalluy

Open access · goldAbstract read
In one paragraph

Article in Journal of cardiovascular development and disease, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 2 pooled it
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 syntheses or guidelines pooled it, 6 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Mar Gomis-PastorDigital Health Department and Pharmacy Department, Hospital de la Santa Creu i Sant Pau, IIB Sant Pau, 08025 Barcelona, Spain.
Sonia Mirabet PerezHeart Failure and Heart Transplant Unit, Cardiology Department, Hospital de la Santa Creu i Santa Pau and CIBER de Enfermedades Cardiovasculares (CIBER-CV), IIB Sant Pau, 08025 Barcelona, Spain.ORCID 0000-0001-5955-2748
Anna De Dios LopezPharmacy Department, Hospital de la Santa Creu i Santa Pau, 08025 Barcelona, Spain.ORCID 0000-0001-5587-3106
Vicenç Brossa LoidiHeart Failure and Heart Transplant Unit, Cardiology Department, Hospital de la Santa Creu i Santa Pau and CIBER de Enfermedades Cardiovasculares (CIBER-CV), IIB Sant Pau, 08025 Barcelona, Spain.
Laura Lopez LopezHeart Failure and Heart Transplant Unit, Cardiology Department, Hospital de la Santa Creu i Santa Pau and CIBER de Enfermedades Cardiovasculares (CIBER-CV), IIB Sant Pau, 08025 Barcelona, Spain.ORCID 0000-0002-8653-6206
Rebeca Pelegrin CruzPharmacy Department, Hospital de la Santa Creu i Santa Pau, 08025 Barcelona, Spain.ORCID 0000-0003-3059-0542
Mª Antonia Mangues BafalluyPharmacy Department, Hospital de la Santa Creu i Santa Pau and CIBER de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), 08025 Barcelona, Spain.ORCID 0000-0002-1438-8515
Centro de Investigación en Red en Enfermedades Cardiovasculares · ESHospital de Sant Pau · ESBiomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

(1) Background: In the mHeart trial, we showed that an eHealth intervention, mHeart, improved heart transplant (HTx) recipients' adherence to immunosuppressive therapy compared with the standard of care. Herein, we present the analysis assessing whether mHeart reduces complication frequency and healthcare resource use, and whether this reduction depends on patients' adherence. (2) Methods: The mHeart was a single-center randomized-controlled trial (IIBSP-MHE-2014-55) in 134 adult HTx recipients (n = 71 intervention; n = 63 controls). The endpoints were mortality, complications, and resource use during follow-up (mean 1.6 ± 0.6 years). (3) Results: A significantly lower proportion of HTx recipients in mHeart had echocardiographic alteration (2.8% vs. 13.8%;

Indexed as

complicationseHealthheart transplantresource use

Identifiers

PMID36826572
PMCPMC9960237
OpenAlexW4319960081

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.